|
Volumn 13, Issue 2, 2001, Pages 409-412
|
The synthetic cannabinoid WIN55212-2 decreases the intraocular pressure in human glaucoma resistant to conventional therapies
|
Author keywords
CB1; Ciliary body; Eye; Marijuana
|
Indexed keywords
2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE;
ANTIGLAUCOMA AGENT;
CANNABINOID RECEPTOR ANTAGONIST;
ADULT;
AGED;
ARTICLE;
BLINDNESS;
CLINICAL ARTICLE;
DRUG EFFECT;
DRUG RESEARCH;
FEMALE;
GLAUCOMA;
HUMAN;
INTRAOCULAR PRESSURE;
MALE;
OPTIC NERVE DISEASE;
PRIORITY JOURNAL;
ADULT;
AGED;
CALCIUM CHANNEL BLOCKERS;
CANNABIS;
CILIARY BODY;
DOSE-RESPONSE RELATIONSHIP, DRUG;
FEMALE;
GLAUCOMA;
HUMANS;
INTRAOCULAR PRESSURE;
MALE;
MIDDLE AGED;
MORPHOLINES;
NAPHTHALENES;
RECEPTORS, CANNABINOID;
RECEPTORS, DRUG;
|
EID: 0035126568
PISSN: 0953816X
EISSN: None
Source Type: Journal
DOI: 10.1046/j.0953-816X.2000.01401.x Document Type: Article |
Times cited : (110)
|
References (35)
|